Kiran Shaw's Immuneel Therapeutics raises $15 million in funding

Immuneel Therapeutics has raised $15 million in Series A funding round co-led by Eight Roads Ventures, True North Fund VI LLP, and F-Prime Capital. The biotech firm was established in 2018 by Biocon Founder Kiran Mazumdar-Shaw, oncologist Dr Siddhartha Mukherjee, and Dr Kush Parmar, 5AM Ventures' Managing Partner. Immuneel Therapeutics offers cell and gene therapy for cancer at affordable prices.